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ABSTRACT
Objectives: The maternal cell contamination in chorionic villus or amniotic fluid presents a serious preanalytical risk for 
prenatal misdiagnosis. The following study presents and validates a novel process for identifying MCC by detecting short 
tandem repeat markers on Ion Proton system. Initially, MCC testing was performed during the detection of chromosomal 
abnormalities so as to improve the detection efficiency and accuracy of this method. 
Material and methods: More than 70 STR loci were selected to establish the detection progress. Capillary electrophoresis 
was used to compare the next generation sequencing  detection results, as well as to identify the optimal STR on Ion Proton 
system. Evaluation criteria for maternal cell contamination were set, and the automated data analysis was performed. The 
detection sensitivity was validated via 4 groups with mixed samples and different proportions. 
Results: Consequently, twenty-three clinical samples were tested to evaluate the detection accuracy. In addition, 14 reli-
able STR loci, which were stably detected in more than 25 samples, were found. The detection sensitivity in maternal cell 
contamination was no less than 20%, while its accuracy reached 100% in clinical samples. 
Conclusions: Finally, we established and validated a novel detection procedure for maternal cell contamination in clinical 
prenatal samples using next generation sequencing. This procedure allowed us to simultaneously perform prenatal test-
ing and MCC testing. Unlike the traditional capillary electrophoresis, this method is rapid, highly sensitive, and suitable for 
wide range of clinical applications.
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INTRODUCTION 
The detection of chromosomal abnormalities in prenatal 
diagnosis based on high-throughput sequencing could 
contribute to explaining the etiology of miscarriage and fetal 
abnormalities. This approach has gradually replaced karyo-
type analysis as the main technique in detecting in clinical 
chromosomal abnormalities [1]. The detection accuracy of 
this approach has shown to be highly correlated with the 
quality of clinical specimens. The quality of clinical speci-
mens is directly related with the accuracy of high-through-
put sequencing detection, while the presence of maternal 
cell contamination in chorionic villus, miscarriage tissue or 
amniotic fluid samples poses a serious analytical risk for 
prenatal misdiagnosis [2]. According to existing literature, 
the proportion of the maternal cell contamination (MCC) 
in amniotic fluid samples is as high as 25% [3]. However, 
contamination of clinical samples with maternal cells can be 
a potential source of error when applying high sensitivity de-
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tection technologies, such as high-throughput sequencing 
technology. Therefore, it is of great importance to accurately 
verify the potential presence of MCC in prenatal samples.
At present, the routine detection of MCC is performed 
by capillary electrophoresis with fluorescent labeled mi-
crosatellites. Short tandem repeats, consisting of 2–6 re-
peating bases, are found in the genome of both, humans 
and mammals. They are highly polymorphic, and are used 
as an important biomarker in forensic identification [4, 5]. 
The short tandem repeat (STR) that has a very high degree 
of polymorphism, can be used for the detection of MCC 
by distinguishing whether the same detection STR allele 
peak appears in maternal sample [6, 7] However, the long 
detection period makes this method unsuitable for clini-
cal applications. It is also inconvenient since it requires for 
large amounts of clinical testing, especially, when com-
pared to next generation sequencing used for detection 
of chromosomal abnormalities from miscarried tissue. The 
method developed in the present study can be used to 
simultaneously detect MCC and miscarried tissue chromo-
somal abnormalities using next generation sequencing 
(NGS) system. It is eminently suitable for clinical application 
due to the low cost, fast applicability and high sensitivity. In 
the present study, we developed a method for detection of 
MCC by identifying STR markers using Ion Proton system. 
The validation of this method in clinical samples proved it 
suitable for MCC detection, thus providing a valuable refer-
ence for MCC in prenatal diagnosis.
MATERIAL AND METHODS 
Sample collection
Different samples were collected for diverse experiments 
in Women and Children’s Hospital of Linyi City. This study was 
approved by the Medicine Ethics Committee of Women and 
Children’s Hospital of Linyi City. All the DNA were extracted 
using TIANamp Genomic DNA Kit (DP304), and were quanti-
fied using Qubit ds DNA HS Assay kit (Q32854). First, 6 samples 
were randomly collected form healthy individuals so as to in-
vestigate the eligibility and assessment of detecting STR using 
Ion Proton System. These samples were also used for detecting 
consistency among NGS-STR and CE-STR. Then, few artificial 
preparation samples were used to examine the sensitivity of 
NGS-STR. Consequently, four group samples were collected, 
and they were obtained from mother-son or mother-daughter. 
Mixtures of DNA samples from two families were prepared 
in mixture ratios of 1:9, 1:4 and 3:7 (mother: child). A total of 
23 clinical samples were used for the detection of chromosom-
al abnormalities. Three positive samples revealed maternal 
cell contamination in chromosome abnormalities, while the 
20 negative samples showed no chromosome abnormalities. 
Process of testing 
Sample detection was done according to four steps: 
primer design, amplification, sequencing and data analysis. 
Primer design
The selected STR markers were collected from STR data-
base TPMD, while the DNA sequence information of target 
markers were collected from GenBank (http://www.ncbi.
nlm.nih.gov/genbank). All STR markers were highly poly-
morphic. Primers for PCR amplification were designed using 
Primer5 software such that they were located in conservative 
region. The amplicon size of the STR markers was < 180 bp 
because of the reads limits on Ion Proton system. 
PCR amplification 
The DNAs from collected and prepared samples were 
used as templates for the PCR reaction. All the microsatel-
lites were amplificated by Premix Taq (TaKaRa Taq Version 
2.0, R004A). PCR reaction was performed in a 20 µL reaction 
volume containing 10 ng of template DNA, 10 µL of 10 × Pre-
mix Taq mix, 0.5 mM of each primer, and nuclease-free wa-
ter. The optimal TM amplification was calculated using the 
following formula: (TM of forward primer + TM of reverse 
primer)/2–2.5. The primer extension was cycled for 30 cycles 
with 15 s at 95°C, 15 s at optimal TM, and 15 s at 72°C.
The amplification products were quantified and mixed 
at an equivalent amount per STR product. The total mixed 
products were purified by the Agencourt Ampure XP Rea-
gent (Beckman, A63882), which was added to 1.5 × volume. 
The purified STR products were eluted with nuclease-free 
water.
Sequencing
Library preparation was performed using the Ion Plus 
Fragment Library Kit Each (Life Technologies, 4471252) with 
no more than 300 ng of purified PCR products, following 
the manufacturer’s instructions; in addition, no fragmenta-
tion was required. The DNA concentration of the libraries 
was estimated using the Qubit ds DNA HS Assay kit (Life 
Technologies, Q32854) according to the manufacturer’s 
instructions. Finally, the library was sequenced on Ion Proton 
System (Life Technologies) using the Ion Pi Hiq Seq 200 Kit 
8 Init 8 Init (Life Technologies, A26772). The sample loading 
was about 50 pmol per library, and 0.5M of raw reads were 
obtained as expected.
NGS data analysis
The sequencing analysis was done according to previous-
ly described approach [8]. Some parameters were adjusted 
according to the Ion Proton System. The redundant sequences 
were filtered by filter rate so as to obtain the exact alleles.
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Capillary Electrophoresis
The fluorescence primers for capillary electrophoresis 
were synthesized according to the primer sequences in next 
generation primer sequencing, while the STR products with 
fluorescence were sent for testing using Applied Biosystems 
3730xl DNA Analyzer. Output data were analyzed using 
GeneMapper Software Version 4.0 (Applied Biosystems).
RESULTS
The feasibility of detecting STR  
on Ion Proton System 
The read lengths on Ion Proton System P1 chip were 
not longer than 275bp, leading to shorter DNA fragment 
lengths. Nevertheless, most STRs have longer length 
than the reading length, varying from 100bp to 300bp, 
with repeats of 2bp mostly. In theory, the alleles in uncon-
taminated samples were no longer than 2, nevertheless 
more than 2 alleles were detected in an uncontaminated 
sample while the STR repeats in 2bp. Moreover, we took into 
consideration the redundant peaks, where stutters were in 
the majority. Stutter is a minor PCR product produced in STR 
amplification, which is one repeat shorter or longer than its 
corresponding allele. A proposed mechanism for stuttering 
is slipped strand mispairing during PCR, resulting in either 
the insertion or deletion of one repeat unit on the new 
strand [9]. We found that the redundant peaks were high in 
2bp repeats STR reads, and sometimes they reached 50% as 
shown in Figure 1, thus leading to incorrect interpretation 
of the results. When the STR repeats were 3bp or 4bp, then 
the amplicon reads were sequenced with relatively low 
rate and number of redundant peaks, while the rate of the 
redundant peaks was no more than 10% in this process. The 
filter rate of 10% means that the redundant reads account 
for 10% of total allele reads. We can filter out these stutters 
and redundant reads through different ratios, while the ratio 
varies from different STR. The STR detecting on Proton has 
two essential requirements after evaluation: STR length no 
longer than 180bp, and repeats in 3bp or 4bp. The better 
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Figure 1. Sequencing results in STR loci of different types 
x-axis represents the repeat length of the corresponding STR loci alleles, while the y-axis is the number of reads. D11S4159 and D11S925 in figure 
1A/1B are STR loci of 2bp repeat, while D22S1045 in figure 1C has 3bp repeat, TPOX in figure 1D has 4bp repeat. It is obvious that D11S4159 and 
D11S925 have multiple alleles, which result in the failed interpretation of true alleles. However, we can get the clear peaks in D22S1045 and TPOX 
after the filtering of stutter
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detecting effect depends on the short STR length, while the 
total number of reads for long length STR is incredibly low 
because of the limitations related to read length. 
Selection and assessment of STR
According to the specific requirements for detection of 
STR using Ion Proton System, 16 highly polymorphic STRs 
which met the qualifications were selected in the present 
study. Eight single samples from 4 family groups were used 
for the verification experiment; 14 STR loci with high stability 
were found (Fig. 2 shows the NGS results from14 STR loci in 
normal human samples). The selection standard for STR loci 
was based on the sequencing quality. One of the requirements 
was that the sequencing read number was > 100 for each al-
lele. The most important factor was the redundant peak rate, 
which was no more than 10%. Thus, we could obtain low spare 
peak rates that in turn could be filtered in sequencing analysis. 
Detecting consistency among NGS-STR  
and CE-STR
In consideration of the international golden standard, 
i.e. using capillary electrophoresis for STR testing, we further 
examined a comparison between capillary electrophoresis 
and NGS in detecting STR, aiming at validating the accuracy 
of STR testing on Ion Proton system. The data in Table 1 show 
the difference between two detection methods. Briefly, we 
find that the STR detection by next generation sequencing 
is more accurate compared to capillary electrophoresis ap-
proach. The testing in capillary electrophoresis has 1–2bp 
bias in STR length, because of the deviation from platform 
Table 1. Consistency detection among NGS-STR and CE-STR
STR Detecting Method Sample 1 Sample 2 Sample 3 Sample 4 Sample 5 Sample 6
D6S1017
CE 153/161 161/172 169/172 161/172 161 161/169
NGS 151/159 159/171 167/171 159/171 159 159/167
D12S391
CE 114/118 122/126 114/122 118 118/122 114
NGS 115/119 123/127 115/123 119 119 115
D17S1301
CE 152/156 144/148 148/156 148/152 156/160 153/157
NGS 154/158 146/150 150/158 150/154 158/162 154/158
GATA165B12
CE 127/140 131 127/131 132/136 131 /139 127/131
NGS 129/141 133 129/133 133/137 133/141 129/13
GATAD172D05
CE 122/126 106/126 122/130 122 106/126 122
NGS 120/124 108/128 124/132 124 124/128 124
DXS6804
CE 114 114/126 114/118 114 114/126 122
NGS 115 115/127 115/119 115 115/127 123
DXS7133
CE 112/116 111 111 111/115 111/115 115
NGS 114/118 114 114 114/118 114/118 118
DXS9902
CE 176/180 172 172 172/176 180 176/180
NG 176/180 172 172 172/176 180 176/180
D22S1045
CE 155/158 152/155 155 139/152 152 152/158
NGS 153/156 150/153 153 138/150 150 150/156
D8S1179
CE 179/183 175 /183 179 171/180 185/193 171/180
NGS 181/185 177/185 181 173/181 185/193 172/181
TH01
CE 170 162/170 170 158/170 162 162/170
NGS 170 162/170 170 158/170 162 162/170
TPOX
CE 113 113/125 124 113/125 112 112/125
NGS 114 114/126 126 114/126 114 114/126
D16S539
CE 150/154 150/158 150/162 150/162 150/162 162/166
NGS 149/153 149/157 149/161 149/161 149/161 161/165
D13S1492
CE 133/141 129/150 137/150 – – –
NGS 133/141 129/149 137/149 – – –
The data in Table 1 shows high consistency among NGS and CE in detecting STR. The CE data represent the detected STR loci length, while the NGS data show the 
assemble length which combined detected repeat length with non-repeat length theoretically of the STR loci. The differences in allele length at one sample show high 
uniformity. The lines”–” mean that D13S1492 have not been detected in these samples
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Figure 2. The sequencing map of 14 STR on Ion Proton System 
14 STR peaks in NGS data. x-axis represents repeated length of different alleles, while the y-axis is the number of reads. The peak height 
represents the number for corresponding alleles. The figure shows the alleles with reads filter rate of 10%
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and process. The deviation is an objective existence. Since 
the primer sequences were the same in two testing plat-
forms, the STR length should in theory be the same. The STR 
length in NGS method (Tab. 1) is the actual length obtained 
by adding the detected sequencing length in repeat region 
and non-repeat region, while the length in capillary elec-
trophoresis method shows the full length of STR product. 
Sometimes 3’ A-tail was added to STR products by using 
the r-Taq polymerase, however, the addition of A-tail failed 
because of the amplification compositions. Therefore, tak-
ing into consideration the “A” tail and deviation in capillary 
electrophoresis platform, we assumed that the difference 
between two detection methods was objective and ac-
ceptable. Therefore, we analyzed the detecting consistency 
among NGS-STR and CE-STR. The aberration in alleles of one 
STR loci showed to be the same between NGS and CE, which 
supported the consistency among NGS-STR and CE-STR.
Standard of MCC interpretation 
It is recommended that two to three informative mi-
crosatellite markers reflecting clearly definable, separate 
maternal and fetal genotypes from among a panel of ap-
proximately 7 to 10 markers be used to assess the presence 
of MCC7. While the maternal sample is absent, we can only 
get the information from fetal genotypes. One simple sam-
ple can provide only two different allele genotypes in one 
STR loci. If three alleles of the autosomal STR (or two X-chro-
mosome STR alleles in sample of male fetus) appear in one 
fetal sample, one of the alleles must come from maternal 
DNA. Therefore, we regarded the STR loci as an informative 
microsatellite marker. Correspondingly, 3 main peaks ap-
peared on the autosomal STR diagram, or 2 main peaks were 
displayed on the X-chromosome STR diagram. Generally, the 
contamination proportion was consistent with the rate of 
the low amount allele which was from maternal genotype. 
With maternal sample, MCC interpretation is much easier, 
since the fetal genotypes are compared with the maternal 
genotypes. If the fetal alleles are the same as maternal alleles 
in STR loci, the STR loci can be regarded as an informative 
microsatellite marker. 
Standard of data analysis
The data were analyzed and evaluated according to 
the existing literature [8]. The STR analysis threshold was 
set based on the results detected from the accumulative 
samples. Sequencing error and PCR stutters exist objectively. 
Stutters are produced in PCR amplification when one repeat 
unit is shorter or longer than the parent allele. Stutters made 
up approximately 10% of the sequence reads, while the 
stutters rates differ in different STR [10]. Due to sequencing 
error and PCR stutters, these sequence reads can be filtered 
by analysis threshold so as to make accurate interpretation. 
Table 2. Filter rate of STR
STR Filter Rate
D6S1017 8.0%
D12S391 8.0%
D17S1301 8.0%
GATA165B12 9.0%
GATA172D05 5.0%
DXS6804 7.0%
DXS7133 6.0%
DXS9902 7.0%
D22S1045 8.0%
D8S1179 8.0%
TH01 6.5%
TPOX 5.0%
D16S539 7.0%
D13S1492 7.0%
The filter rate list is shown in Table 2. These analysis threshold 
values were determined in view of the expected allele reads 
for maternal minor component from the total reads at each 
of the mixture proportion in below 4 family samples, while 
in the previous studies threshold value was set to10% or 5% 
following the same approach [11]. 
Sensitivity of NGS-STR
Four group mother-child samples were used to evalu-
ate the detecting sensitivity. Mixtures were prepared in 
mixture ratios of 1:9, 1:4 and 3:7 (mother: child), with the 
proportion of maternal DNA 10%, 20% and 30%, respec-
tively. The mother sample and child sample were tested so as 
to obtain the correct alleles in single sample. Consequently, 
the alleles in the mixtures were analyzed according to the 
results from a single sample. Thus, the detecting sensitivity 
was analyzed through the emerged maternal allele in cor-
responding proportion of mixtures. As shown in Table 3, we 
found that < 20% mixtures could be identified by 14 STR loci 
following this detection process. Unfortunately, certain 10% 
mixtures could not be identified, since the actual allele rate 
was similar to stutters rate in some STR loci. 
Validation of positive and negative clinical 
samples
Three samples were not detected because of suspected 
MCC in chromosome karyotypes analysis. These three sam-
ples were also validated by capillary electrophoresis, which 
showed consistency with the NGS results. We tested the 
3 samples with the following process and method. Sample 
1 and Sample 3 were male fetuses, while Sample 2 was 
a female fetus. Sex of fetuses helped us to get more accurate 
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and convenient discrimination in laboratory experi-
ments; no more than one allele was found in a single 
male fetus while the STR were located in chromo-
some X. STR of DXS6804 and GATA172D05 were in 
X chromosome, while other STR loci were autoso-
mal STR. According to the standard criteria for MCC 
detection, more than 2 informative microsatellite 
markers need to be detected in 3 samples. The 
3 abortive tissue samples revealed MCC, not only 
in capillary electrophoresis system but also using 
the next generation system. In Figure 3, we show 
both the CE result and the NGS result, while the CE 
figure implies the total length of STR products in this 
sample, and the NGS figure stands for the repeat 
length of STR in the sample. Although the results 
displayed the different form of length, the number 
of alleles and the difference in length between al-
leles showed high consistency in the same STR.
Twenty normal samples in chromosome karyo-
types analysis, which were from different sample 
types of CVS, AF and blood, were collected to verify 
the detecting method. All of the samples suggested 
the absence of MCC under this test. Also, all of the 
twenty samples were tested by capillary electro-
phoresis, which revealed the same results as NGS, 
i.e. 20 examined samples were negative for MCC.
DISCUSSION
MCC in a prenatal diagnosis is an important fac-
tor, which is often overlooked by many laborato-
ries. The British Association of Clinical Molecular Ge-
netics (CMGS) developed practice guidelines for test-
ing maternal cell contamination in prenatal samples 
for molecular studies. According to these, all prenatal 
diagnoses for single gene disorders should include 
MCC testing [12]. In 2010, American Society for Inves-
tigative Pathology and the Association for Molecular 
Pathology published the Laboratory Guidelines for 
Detection, Interpretation, and Reporting of Maternal 
Cell Contamination in Prenatal Analyses, suggesting 
that maternal samples should be obtained parallel 
with prenatal specimens so as to eliminate the po-
tential impact of MCC [7]. These guidelines state that 
maternal and prenatal specimens should be tested 
and analyzed for MCC concurrently within the same 
analysis so as to allow for a direct comparison of re-
sults. The basic premise is the comparison of highly 
polymorphic short tandem repeat/microsatellite loci 
between the maternal and fetal DNA samples. It has 
been suggested that two to three informative micro-
satellite markers can clearly reflect the presence of 
MCC, while 7 to 10 markers are enough to assess the T
ab
le
 3
. T
he
 N
G
S-
ST
R 
re
su
lts
 fr
om
 4
 sa
m
pl
es
 g
ro
up
s
ST
R
A
B
A/
B 
= 
1:
4
A/
B 
= 
3:
7
C
D
C/
D
 =
 1
:4
C/
D
 =
 3
:7
E
F
E/
F 
= 
1:
4
E/
F 
= 
3:
7
G
H
G
/H
 =
 1
:4
G
/H
 =
 3
:7
D
6S
10
17
40
/4
8
48
/5
2
40
/4
8/
52
40
/4
8/
52
40
/5
2
40
40
40
32
/4
0
32
/4
0
32
/4
0
32
/4
0
40
/4
8
32
/4
8
32
/4
0/
48
32
/4
0/
48
D
12
S3
91
52
/5
6
48
/5
6
48
/5
2/
56
48
/5
2/
56
48
/5
2
52
/5
6
48
/5
2/
56
48
/5
2/
56
44
/4
8
44
/4
8
44
/4
8
44
/4
8
48
/5
6
52
/5
6
48
/5
2/
56
48
/5
2/
56
D
17
S1
30
1
48
/5
2
44
/4
8
44
/4
8
44
/4
8/
52
40
/4
4
40
/4
4
40
/4
4
40
/4
4
40
/4
4
40
/4
4
40
/4
4
40
/4
4
40
/4
8
36
/4
0
36
/4
0
40
/4
8/
36
GA
TA
16
5B
12
32
/3
6
36
32
/3
6
32
/3
6
36
36
/4
0
36
/4
0
36
/4
0
32
/4
0
32
32
/4
0
32
/4
0
32
/4
0
32
32
/4
0
32
/4
0
GA
TA
17
2D
05
32
/4
0
40
32
/4
0
32
/4
0
40
/4
4
32
/4
0
32
/4
0/
44
32
/4
0/
44
32
/4
4
44
32
/4
4
32
/4
4
24
/4
4
24
/4
4
24
/4
4
24
/4
4
DX
S6
80
4
44
/4
8
44
/4
8
44
/4
8
44
/4
8
52
/5
6
52
/5
6
52
/5
6
52
/5
6
52
/5
6
52
/5
6
52
/5
6
52
/5
6
44
44
/5
6
44
/5
6
44
/5
6
DX
S7
13
3
36
36
36
36
36
/4
0
36
/4
0
36
/4
0
32
/4
0
36
36
36
36
36
/4
0
36
36
/4
0
36
/4
0
DX
S9
90
2
40
/4
8
48
40
/4
8
40
/4
8
40
/4
4
40
40
40
/4
4
44
/4
8
48
44
/4
8
44
/4
8
44
/4
8
44
/4
8
44
/4
8
44
/4
8
D
22
S1
04
5
30
/3
6
36
30
/3
6
30
/3
6
36
36
/4
2
36
/4
2
36
/4
2
24
/3
6
24
/4
2
24
/3
6/
42
24
/3
6/
42
21
/2
4
24
/4
2
24
/4
2
21
/2
4/
42
D
8S
11
79
48
/5
2
44
/5
2
44
/4
8/
52
44
/4
8/
52
52
/5
6
48
/5
6
48
/5
2/
56
48
/5
2/
56
56
/6
4
60
/6
4
56
/6
0/
64
56
/6
0/
64
48
/5
2
48
/5
2
48
/5
2
48
/5
2
TH
01
28
/3
6
28
/3
6
28
/3
6
28
/3
6
28
28
/3
6
28
/3
6
28
/3
6
32
/3
6
36
32
/3
6
32
/3
6
36
36
36
36
TP
O
X
32
/4
4
32
/4
4
32
/4
4
32
/4
4
32
/4
4
32
/4
4
32
/4
4
32
/4
4
32
32
/3
6
32
/3
6
32
/3
6
32
/4
4
32
/4
4
32
/4
4
32
/4
4
D
16
S5
39
36
/4
8
36
/4
8
36
/4
8
36
/4
8
36
/4
4
36
/5
2
36
/4
4/
52
36
/4
4/
52
48
/5
2
36
/4
8
36
/4
8
36
/4
8/
52
40
/4
4
40
/4
4
40
/4
4
40
/4
4
D
13
S1
49
2
48
/6
8
48
/5
6
48
/5
6/
68
48
/5
6/
68
52
/6
0
56
/6
0
52
/5
6/
60
–
–
–
–
–
–
–
–
–
Sa
m
pl
es
 A
, C
, E
 a
nd
 G
 re
pr
es
en
t m
at
er
na
l D
NA
, w
hi
le
 B
, D
, F
 a
nd
 H
 re
pr
es
en
t c
hi
ld
’s 
DN
A.
 Th
e 
nu
m
be
rs
 sh
ow
n 
in
 th
e 
ta
bl
e 
st
an
d 
fo
r t
he
 re
pe
at
 re
gi
on
 le
ng
th
 o
f S
TR
 a
lle
le
. T
he
 re
d 
fo
nt
s a
re
 th
e 
m
at
er
na
l a
lle
le
 w
hi
ch
 w
er
en
’t 
de
te
ct
ed
 in
 th
e 
m
ix
tu
re
s. 
Th
e 
lin
es
”–
” 
m
ea
n 
th
at
 D
13
S1
49
2 
w
er
e 
no
t d
et
ec
te
d 
in
 th
os
e 
sa
m
pl
es
. D
at
a 
sh
ow
n 
in
 th
e 
ta
bl
es
 a
re
 th
e 
fin
al
 a
lle
le
s a
fte
r t
he
 se
qu
en
cin
g 
ra
w
 d
at
a 
w
er
e 
fil
te
re
d.
 Th
e 
de
te
ct
ed
 re
su
lts
 in
 1
0%
 m
ix
tu
re
 w
er
e 
no
t s
ho
w
n 
in
 th
e 
ta
bl
e 
du
e 
to
 lo
w
 d
et
ec
tio
n 
ra
te
 o
f m
at
er
na
l S
TR
 a
lle
le
 
333
Xiaojie Lin et al., NGS as a new detection strategy for MCC
www. journals.viamedica.pl/ginekologia_polska
Figure 3. The detection results of 3 positive MCC samples by using NGS-STR and CE-STR 
The MCC detected results using NGS-STR from 3 uncertain MCC in chromosomes karyotypes analysis. Sample I, II and III represents different 
positive sample. The upper graphs are the informative STR results by capillary electrophoresis, while the below graph showes the same informative 
STR results by NGS. Other non-informative results were not displayed
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presence of MCC. However, in order to save time and cost in 
detection of prenatal analyses, in most of the cases only the 
fetus analysis is performed. In the US, most of the laboratories 
perform MCC detection on prenatal diagnosis clinical sam-
ple [6]. The level of detection for MCC assays varies from 1 to 
20%, while the number of markers ranges from 9 to 16 [13]. 
In addition, previous studies have suggested the use of STR 
biomarkers for detection of MCC [14, 15].
Different studies have revealed different incidence rates 
of maternal contamination in chorionic villus, miscarriage 
tissue or amniotic fluid samples in prenatal diagnosis [16, 
17]. Some of the existing studies have shown that the pro-
portion of MCC in amniotic fluid samples is higher compared 
to sample types, while some other studies have indicated 
that the chorionic villus has higher proportion [18, 19]. How-
ever, it is necessary to perform MCC detection in prenatal 
diagnosis regardless of these incidence variations among 
sample types [6, 20]. The existing methods used in clinical 
applications for the routine detection of MCC have many 
disadvantages such as the high cost, long application period 
and lack of automatic data analysis. 
In the present study, we developed an effective method 
for detection of maternal cell contamination using STR bio-
markers. Fourteen STRs with high polymorphism were veri-
fied in MCC detection using Ion Proton system. The validation 
with positive and negative samples supported the feasibility 
of the process suggested for the detection of MCC. The devel-
oped assay shows many advantages in MCC testing such as 
lower detection limit of 20%; simple process of detection in 
the absence of maternal samples; quick testing time (within 
one working day); automatic analysis in sequencing data; 
lower cost and extremely low output data. Also, the STR 
products can be prepared for library construction and can be 
mixed with any other fragmented product samples. 
CONCLUSIONS
In the present study, we introduced a rapid and highly-
-sensitive method for MCC in prenatal diagnosis, which may 
be used as a reference method for MCC detection.
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